104540.KQ Corentec Co Ltd
- Market cap
- KRW 66.5B
- P/E
- 9.9x
- P/B
- 0.80x
- ROE
- 5.7%
- Dividend yield
- 0.65%
- Fundamental score
- 2.9/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 104540.KQ undervalued?
Graham number104540.KQ trades 40.6% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Corentec Co Ltd fundamental analysis
14 of 22 checks passedROE 0/2
Low return on equity (5.7%), below 10%.
ROA 0/1
Return on assets (2.9%) is below the industry median (6.2%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 1/1
Last year's EPS growth (342.2%) is above the 5-year average (29.3% a year).
Earnings Growth vs Industry 1/1
Last year's EPS growth (342.2%) is above the industry median (0.5%).
Revenue Growth 2/2
Revenue grew 16.3% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (1.8%), 40% or less.
Debt Trend 1/1
Debt to equity has not risen over the past 5 years.
Debt Coverage 1/1
Operating cash flow covers 20% of total debt.
Interest Coverage 1/1
EBIT is 5.1x against interest expense, well covered.
PE vs Market 1/1
PE (9.9x) is below the market median (11.3x).
PE vs Industry 0/1
PE (9.9x) is above the industry median (7.6x).
PBV 0/1
Price to book (0.8x) is above the industry median (0.7x).
Graham Number 1/1
The price is below the Graham number (PE x PB = 7.9, limit 22.5).
PEG 1/1
PEG on 5-year earnings growth is 0.34, growth is cheap.
Dividend Yield 0/2
Dividend yield (0.7%) is in the bottom 25% of dividend payers in the market.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 1/1
Payout ratio is 6.9%, covered by earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Corentec Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Corentec Co Ltd
Corentec Co., Ltd., develops and sells orthopedic artificial joints in South Korea. Its orthopedic products include hip systems, such as Bencox ID stems, Bencox stems, Bencox modular revision stems, Bencox m stems, and Benfix long stems; and Bencox cups, Bencox bipolar cups, Bencox mirabo cups, and Bencox mirabo multi-hole cups. The company also offers Lospa and Exult knee systems; spine systems, such as Lospa IS systems; Coralis shoulder systems; and trauma systems, includi…
Full company profileCorentec Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Corentec Co Ltd annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 36.0B | 37.8B | 33.4B | 40.2B | 40.5B | 44.6B | 63.9B | 92.0B | 93.7B | 100B | 101B |
| Gross Profit | 21.2B | 22.3B | 18.2B | 25.0B | 24.6B | 27.2B | 40.0B | 51.7B | 49.9B | 52.1B | 52.4B |
| Operating Income | 433M | -7.35B | -28.3B | 2.34B | 3.32B | 2.79B | 7.50B | 6.35B | 2.77B | 9.30B | 4.68B |
| EBITDA | - | - | - | - | - | - | 9.95B | 15.7B | 9.86B | 14.5B | 12.5B |
| Net Income | 466M | -7.38B | -29.8B | 2.51B | 1.57B | 764M | 1.78B | 4.06B | -2.58B | 6.26B | 4.75B |
| EPS | 47 | -743 | -2,995 | 237 | 135 | 65 | 144 | 318 | -202 | 490 | 372 |
| Balance Sheet | |||||||||||
| Total Assets | 96.0B | 101B | 64.3B | 62.8B | 96.1B | 119B | 172B | 187B | 186B | 172B | 165B |
| Total Liabilities | 35.8B | 46.3B | 40.2B | 32.8B | 49.7B | 62.3B | 106B | 101B | 114B | 82.8B | 71.0B |
| Shareholders' Equity | 60.2B | 54.3B | 24.1B | 29.9B | 46.4B | 56.6B | 65.7B | 73.8B | 72.0B | 78.4B | 83.2B |
| Cash & Short-term Investments | 24.5B | 14.5B | 8.35B | 4.13B | 20.5B | 40.1B | 39.7B | 21.8B | 17.5B | 17.8B | 23.1B |
| Total Debt | - | - | 24.5B | 12.2B | 33.0B | - | - | - | - | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 2.94B | 5.86B | 5.26B | 3.86B | -3.61B | 4.08B | 10.6B | 2.63B | -6.61B | 26.5B | 17.1B |
| Capital Expenditure | 11.9B | 14.0B | 3.95B | 3.30B | 6.40B | 8.39B | 6.15B | 11.8B | 6.13B | 3.59B | 4.28B |
| Free Cash Flow | - | - | - | -7.57B | -10.5B | -4.48B | 3.90B | -9.19B | -12.7B | 22.9B | 12.8B |
| Ratios | |||||||||||
| ROE | 0.8% | -13.6% | -123.6% | 8.4% | 3.4% | 1.3% | 2.7% | 5.5% | -3.6% | 8.0% | 5.7% |
| ROA | 0.5% | -7.3% | -46.3% | 4.0% | 1.6% | 0.6% | 1.0% | 2.2% | -1.4% | 3.6% | 2.9% |
| Net Profit Margin | 1.3% | -19.5% | -89.1% | 6.2% | 3.9% | 1.7% | 2.8% | 4.4% | -2.8% | 6.2% | 4.7% |
| Debt to Equity | - | - | 1.02x | 0.41x | 0.71x | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Corentec Co Ltd dividends
- Dividend yield
- 0.65%
- Forward dividend
- -
- Payout ratio
- 6.9%
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | KRW 433M | 34 | 6.9% |
| 2024 | KRW 931M | 73 | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Corentec Co Ltd
- Insiders 18.67%
- Institutions 0.02%
- Public & others 81.31%
- Shares outstanding 13.4M
- Free float 10.8M
Corentec Co Ltd company profile
- Company name
- Corentec Co Ltd
- Ticker
- 104540.KQ
- ISIN
- KR7104540000
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 175
- Fiscal year end
- December
- Address
- 12, Yeongsanhong 1-gil, Cheonan-si, South Korea, 31056
- Phone
- 82 4 1585 7114
- Website
- corentec.com
About Corentec Co Ltd
Corentec Co., Ltd., develops and sells orthopedic artificial joints in South Korea. Its orthopedic products include hip systems, such as Bencox ID stems, Bencox stems, Bencox modular revision stems, Bencox m stems, and Benfix long stems; and Bencox cups, Bencox bipolar cups, Bencox mirabo cups, and Bencox mirabo multi-hole cups. The company also offers Lospa and Exult knee systems; spine systems, such as Lospa IS systems; Coralis shoulder systems; and trauma systems, including LCfit HTO plate systems and Optirad volar plate system. Corentec Co., Ltd. was founded in 2000 and is headquartered in Cheonan-si, South Korea.
Corentec Co Ltd management
2- Bon-chul KooChief Executive Officer
- Mr. Michael SonExecutive Vice President